Brevetti
Brevetti

Our patents

Our tireless, passionate research work allows us to develop patents of new formulas and technologies.
Thanks to our research laboratories, from 2005 to today​ we have filed 17 patents.

311

311®

GRANTED: 2005

DEVELOPED TO: promote repair of the epidermal barrier, restoring structure and function. Formulated in close collaboration with dermatologists, it can be associated with atopic dermatitis treatments or used on its own by patients who cannot use conventional drug therapies.

Microceramid

MICROCERAMID®

CONCESSO: 2010

DEVELOPED TO: restore and maintain a healthy epidermal structure.

Calendula

CALENDULA ALPIDIOLO®

GRANTED: 2011

DEVELOPED TO: obtain an extract of Calendula officinalis with a high percentage of natural ingredients which can be used in soothing, protective cosmetics.

DESCRIPTION: This patent carries and boosts the efficacy of the extract of Calendula flowers grown by Unifarco on the edge of the Belluno Dolomites National Park. 
The active ingredient, which is obtained using a supercritical extraction technology, is highly concentrated, pure and environmentally friendly.

Osmoshield

OSMOSHIELD®

GRANTED: 2012

DEVELOPED TO: restore balance and promote skin cell communication to fight all signs of skin aging.

Isopalmide

ISOPALMIDE®

GRANTED: 2014

DEVELOPED TO: reduce skin inflammation mediators while soothing the skin.

Clorex

CSU®

GRANTED: 2014

DEVELOPED TO: treat psoriasis in infants and adults topically.
An active response to the needs of psoriasis-prone skin.

OSMO Ik-hair

OSMO IK-HAIR®

GRANTED: 2016

DEVELOPED TO: revitalise and protect hair, strengthening it from the hair bulb upwards. 

Clorex

CLOREX A2G​®

PENDING: 2017

DEVELOPED TO: maintain oral health and hygiene as both an intensive treatment and daily care. 

Tensioblender

TENSIOBLENDER 4.10®

GRANTED: 2017

DEVELOPED TO: cleanse acne-prone skin gently.

Echinoshield

ECHINOSHIELD®

PENDING: 2020

DEVELOPED TO: boost the body’s natural defences. Immunomodulating action demonstrated in vitro.

Ialudeep

IALUDEEP®

GRANTED: 2019

DEVELOPED TO: prevent and treat skin aging, thanks to its intensive antioxidant and hydrating action.

BP Barrier

BP BARRIER 3.1®

PENDING: 2021

DEVELOPED TO: restore and maintain intestinal barrier wellbeing.

Berry Defence

BERRY DEFENCE®

PENDING: 2020 (ITA) 2021 (EPO)

DEVELOPED TO: treat low urinary tract problems and encourage normal function. It also helps eliminate body fluids and has an antioxidant action.

Eco piping

ECO PIPING BAG®

PENDING: 2020

DEVELOPED TO: contain skincare products.

Larixicina

LARIXICINA®

PENDING: 2021

DEVELOPED TO: aid function of the mucous membranes of the respiratory system.

Tecnologia P4-SIV

Tecnologia P4-SIV®

PENDING: 2021

DEVELOPED TO: treat ulcers and microlesions in the mouth.